|
TMPO expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.636800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.263200E-03 |
| Normal-vs-Stage2 |
5.268200E-02 |
| Normal-vs-Stage3 |
1.016820E-03 |
| Normal-vs-Stage4 |
1.942230E-01 |
| Stage1-vs-Stage2 |
8.077000E-01 |
| Stage1-vs-Stage3 |
1.414800E-01 |
| Stage1-vs-Stage4 |
3.868400E-01 |
| Stage2-vs-Stage3 |
4.726200E-01 |
| Stage2-vs-Stage4 |
4.319400E-01 |
| Stage3-vs-Stage4 |
6.596400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.917600E-03 |
| Normal-vs-AfricanAmerican |
7.75550000000624E-05 |
| Normal-vs-Asian |
8.743200E-01 |
| Caucasian-vs-AfricanAmerican |
4.160600E-03 |
| Caucasian-vs-Asian |
4.429600E-01 |
| AfricanAmerican-vs-Asian |
5.054300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.415200E-03 |
| Normal-vs-Female |
5.138600E-03 |
| Male-vs-Female |
4.616400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.115300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.734500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.082900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.479640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.334800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.620800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.128000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.890600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.186300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.759150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.732600E-01 |
| Normal-vs-Grade 2 |
6.083900E-02 |
| Normal-vs-Grade 3 |
1.859560E-03 |
| Normal-vs-Grade 4 |
2.444100E-02 |
| Grade 1-vs-Grade 2 |
8.425400E-01 |
| Grade 1-vs-Grade 3 |
2.879800E-01 |
| Grade 1-vs-Grade 4 |
3.537200E-01 |
| Grade 2-vs-Grade 3 |
5.584100E-02 |
| Grade 2-vs-Grade 4 |
2.763400E-01 |
| Grade 3-vs-Grade 4 |
9.423400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.427580E-01 |
| Normal-vs-ccB subtype |
1.582690E-03 |
| ccA subtype-vs-ccB subtype |
1.526330E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.103300E-03 |
| Normal-vs-N1 |
4.901000E-01 |
| N0-vs-N1 |
5.888200E-01 |
|
|
